Stocks and Investing
Stocks and Investing
Mon, July 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Rick Wise Maintained (TMCI) at Strong Buy with Decreased Target to $21 on, Jul 18th, 2022
Rick Wise of Stifel, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Decreased Target from $32 to $21 on, Jul 18th, 2022.
Rick has made no other calls on TMCI in the last 4 months.
There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 0 agree with Rick's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Rick
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $22 on, Friday, July 15th, 2022
- Ryan Zimmerman of "BTIG" Initiated at Strong Buy and Held Target at $22 on, Thursday, May 12th, 2022
Contributing Sources